{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:53:43Z","timestamp":1793321623709,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.amjmed.2006.08.033","type":"journal-article","created":{"date-parts":[[2007,8,4]],"date-time":"2007-08-04T07:11:35Z","timestamp":1186211495000},"page":"713-719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":851,"title":["Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis"],"prefix":"10.1016","volume":"120","author":[{"given":"Sripal","family":"Bangalore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gayathri","family":"Kamalakkannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanobar","family":"Parkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz H.","family":"Messerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2006.08.033_bib1","series-title":"2004 Heart and Stroke Statistical Update","year":"2004"},{"key":"10.1016\/j.amjmed.2006.08.033_bib2","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archinte.1992.00400190110021","article-title":"Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial","volume":"152","author":"Neaton","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjmed.2006.08.033_bib3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1053\/euhj.2001.2888","article-title":"Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women","volume":"23","author":"Thomas","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjmed.2006.08.033_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.08.033_bib5","first-page":"2658","article-title":"The Steno-2 study","volume":"165","author":"Gaede","year":"2003","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.amjmed.2006.08.033_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/147323000203000111","article-title":"Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients","volume":"30","author":"Dailey","year":"2002","journal-title":"J Int Med Res"},{"key":"10.1016\/j.amjmed.2006.08.033_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/fampra\/17.3.261","article-title":"The development of polypharmacy","volume":"17","author":"Veehof","year":"2000","journal-title":"Fam Pract"},{"key":"10.1016\/j.amjmed.2006.08.033_bib8","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2006.08.033_bib9","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2006.08.033_bib10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJM199304013281303","article-title":"Single-drug therapy for hypertension in men","volume":"328","author":"Materson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2006.08.033_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/bmj.315.7101.154","article-title":"Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study","volume":"315","author":"Philipp","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2006.08.033_bib12","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.amjmed.2006.08.033_bib13","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2165\/00003495-200161070-00004","article-title":"Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension","volume":"61","author":"Ruzicka","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.amjmed.2006.08.033_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/08037050152112041","article-title":"Treatment strategy to control blood pressure optimally in hypertensive patients","volume":"10","author":"Waeber","year":"2001","journal-title":"Blood Press"},{"issue":"9 Suppl","key":"10.1016\/j.amjmed.2006.08.033_bib15","first-page":"7","article-title":"Medication noncompliance: what is the problem?","volume":"9","author":"Dezii","year":"2000","journal-title":"Manag Care"},{"key":"10.1016\/j.amjmed.2006.08.033_bib16","first-page":"150","article-title":"Adherence to medication regimens and recommended lifestyle changes in patients with cardiovascular disease","volume":"3","author":"Ziegelstein","year":"2003","journal-title":"Adv Stud Med"},{"key":"10.1016\/j.amjmed.2006.08.033_bib17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/hrt.80.5.437","article-title":"Preventable causative factors leading to hospital admission with decompensated heart failure","volume":"80","author":"Michalsen","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.amjmed.2006.08.033_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00007611-200295010-00014","article-title":"Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes","volume":"95","author":"Dezii","year":"2002","journal-title":"South Med J"},{"key":"10.1016\/j.amjmed.2006.08.033_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1345\/aph.1E163","article-title":"Persistence with antihypertensives related to formulation: the case of nifedipine","volume":"39","author":"Breekveldt-Postma","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.amjmed.2006.08.033_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1524-6175.2005.04533.x","article-title":"Single-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine\/atorvastatin gemini study)","volume":"7","author":"Blank","year":"2005","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.amjmed.2006.08.033_bib21","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1046\/j.1463-1326.2003.00297.x","article-title":"Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide\/metformin tablets as compared to glyburide co-administered with metformin","volume":"5","author":"Blonde","year":"2003","journal-title":"Diabetes Obes Metab"},{"issue":"9 Suppl","key":"10.1016\/j.amjmed.2006.08.033_bib22","first-page":"2","article-title":"A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension","volume":"9","author":"Dezii","year":"2000","journal-title":"Manag Care"},{"key":"10.1016\/j.amjmed.2006.08.033_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00002030-200004140-00006","article-title":"Efficacy, safety, and adherence with a twice-daily combination lamivudine\/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection","volume":"14","author":"Eron","year":"2000","journal-title":"AIDS"},{"issue":"2 Suppl","key":"10.1016\/j.amjmed.2006.08.033_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0041-3879(87)80021-1","article-title":"United States Public Health Service Tuberculosis Therapy Trial 21: preliminary results of an evaluation of a combination tablet of isoniazid, rifampin and pyrazinamide","volume":"68","author":"Geiter","year":"1987","journal-title":"Tubercle"},{"key":"10.1016\/j.amjmed.2006.08.033_bib25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0149-2918(02)85047-0","article-title":"Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy","volume":"24","author":"Melikian","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.amjmed.2006.08.033_bib26","first-page":"1029","article-title":"Fixed-dose combination chemotherapy (Rifater\/Rifinah) for active pulmonary tuberculosis in Taiwan: a two-year follow-up","volume":"6","author":"Su","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.amjmed.2006.08.033_bib27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1527-5299.2003.03269.x","article-title":"Adherence to antihypertensive therapy with fixed-dose amlodipine besylate\/benazepril HCl versus comparable component-based therapy","volume":"9","author":"Taylor","year":"2003","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.amjmed.2006.08.033_bib28","first-page":"86","article-title":"Sbe24: metan \u2013 an alternative meta-analysis command","volume":"8","author":"Bradburn","year":"1998","journal-title":"Stata Tech Bull Reprints"},{"key":"10.1016\/j.amjmed.2006.08.033_bib29","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/sim.4780070807","article-title":"A note on graphical presentation of estimated odds ratios from several clinical trials","volume":"7","author":"Galbraith","year":"1988","journal-title":"Stat Med"},{"key":"10.1016\/j.amjmed.2006.08.033_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.amjmed.2006.08.033_bib31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.HYP.25.3.305","article-title":"Prevalence of hypertension in the US adult population","volume":"25","author":"Burt","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.amjmed.2006.08.033_bib32","doi-asserted-by":"crossref","first-page":"57S","DOI":"10.1016\/S0895-7061(00)00273-9","article-title":"Worldwide trends and shortcomings in the treatment of hypertension","volume":"13","author":"Julius","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.amjmed.2006.08.033_bib33","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2006.08.033_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2337\/diacare.25.1.213","article-title":"Standards of medical care for patients with diabetes mellitus","volume":"25","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjmed.2006.08.033_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2337\/diacare.21.1.87","article-title":"UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes","volume":"21","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjmed.2006.08.033_bib36","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","article-title":"A strategy to reduce cardiovascular disease by more than 80%","volume":"326","author":"Wald","year":"2003","journal-title":"BMJ"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293430601151X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293430601151X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:45:42Z","timestamp":1757580342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293430601151X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S000293430601151X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2006.08.033","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2006.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}